Category: News

2020 was a year like no other, especially for gold prices. Facing economic volatility, investors flocked to gold for its value-holding properties. With gold still trading above US$1,800 an ounce, the trend looks like it’s set to continue through 2021.

Energy Resources Australia (ASX: ERA) has ceased uranium production at its Ranger mine in the Northern Territory after 40 years of extracting the yellow metal.

Australian clinical stage biotech company Prescient Therapeutics (ASX: PTX) will undertake three internal development programs to advance its state-of-the-art cancer treatment, OmniCAR.

More than one in every four people globally reportedly play games on their mobile devices, helping grow the video game market into an almost $US180 billion entertainment juggernaut.

When Amazon CEO Jeff Bezos became the world’s richest person in 2017, Elon Musk was number 21. A respectable number, maybe, but barely under Bezos’ radar.

“Investors can take advantage of 2020’s structural market changes by looking to invest in companies with smaller market capitalisations” says Yarra Capital Management microcap portfolio manager Joel Fleming.

Following more than a decade of treatments, cancer survivor Laurie Adami now plans to tackle the world’s tallest mountain to raise awareness of the drugs that saved her life.

Australian independent games developer Playside Studios is looking to take a slice of the US$200 billion global gaming industry following a successful mid-December IPO.

Nickel prices are tipped to keep climbing in 2021 following a volatile year that saw the commodity beat expectation, despite some weakness early in the year.

Amid the tragedy of 2020’s global COVID-19 pandemic, it’s easy to forget the horrors inflicted on hundreds of thousands of Australians by another deadly illness: cancer.

Further exploration work at Nusantara’s (ASX: NUS) Awak Mas Gold Project in Indonesia has uncovered a number of potential high-grade feeder structures.

Australia’s blossoming medicinal cannabis industry is poised for a year of growth following regulatory changes made by the Therapeutic Goods Administration (TGA).